Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1185 per EA under NDC 27241011904. Its NADAC has been published 391 times since Feb 27, 2019.
FDA first approved this application on Sep 10, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
134 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241011904
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA210705FDA Approved
9/10/2018
TE Code
AB
On Market Since
9/10/2018
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 391 times since Feb 27, 2019, and over the history we have for it it has declined 72.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1185 per EA |
|---|---|
| All-time high | $0.4625 (Jun 12, 2019) |
| All-time low | $0.1020 (Nov 20, 2024) |
| 52-week high | $0.1391 |
| 52-week low | $0.1101 |
| Median price | $0.1426 |
| Average price | $0.2001 |
| Largest weekly change | +38.9% (Sep 23, 2020) |
| Weeks tracked | 391 |
| Tracking since | Feb 27, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.1185 per EA (NDC 27241011904), effective Aug 19, 2026.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 72.5%. It has been tracked across 391 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since Feb 27, 2019, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1020 (Nov 20, 2024) to a high of $0.4625 (Jun 12, 2019), with a median of $0.1426 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 134 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 27241011904) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.